Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We report three patients with cystic fibrosis and one patient with primary biliary cirrhosis and plexogenic pulmonary hypertension who have undergone heart-lung-liver transplantation as a combined procedure. Liver transplantation was necessary in the three patients with cystic fibrosis because of portal hypertension secondary to either hepatic fibrosis or established cirrhosis in addition to their advanced lung disease. Three of the four patients were alive at 20, 50, and 100 months after transplantation (one patient with cystic fibrosis died on day 16 of pneumonia) with well-preserved pulmonary function (forced expiratory volume in 1 second 110%, 49%, and 100% predicted, respectively), normal hepatic function and New York Heart Association class 1 performance status. Heart-lung and concurrent liver transplantation is a feasible and successful procedure with a satisfactory long-term outcome in selected patients with advanced pulmonary and hepatic disease.


Journal article


J Heart Lung Transplant

Publication Date





536 - 538


Adult, Bronchitis, Cause of Death, Cystic Fibrosis, Feasibility Studies, Female, Follow-Up Studies, Forced Expiratory Volume, Graft Rejection, Heart Transplantation, Humans, Hypertension, Portal, Hypertension, Pulmonary, Liver Cirrhosis, Liver Cirrhosis, Biliary, Liver Transplantation, Lung Transplantation, Male, Patient Selection, Pneumonia, Bacterial, Pseudomonas Infections, Pseudomonas aeruginosa, Survival Rate, Treatment Outcome